Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve This is to inform that a meeting of ....
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pfizer Ltd has scheduled a board meeting on May 12, 2026 to consider and approve the financial results for Q4 and FY ended March 31, 2026. The meeting will also consider recommending a dividend for FY 2025-26. The company has closed its trading window from March 31, 2026 until 48 hours after the results are made public on May 12, 2026. This is a standard regulatory intimation under SEBI Listing Regulations. No specific financial figures or business updates have been disclosed in this notice.
This is a routine board meeting notice. The announcement of dividend consideration could be a positive signal for shareholders if a dividend is subsequently approved. No material impact on stock until actual results are released.